Glycophos
- Product NDC
- 63323-241
- 11-digit product format
- 633230241
- Labeler code
- 63323
- Product ID
- 63323-241_aeed61b6-c0c3-416d-be37-991dd58a4950
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SODIUM GLYCOLATE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
- Marketing start
- 2013-05-13
- Marketing end
- 0000-00-00
- Substance
- SODIUM GLYCEROPHOSPHATE ANHYDROUS
- Active strength
- 216 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| efd58dcf-540a-4531-8766-e713129ca6f2 | Product name | 1 | 20250307 |
| 4b7700e3-6e0e-45e5-9d22-6f754d61386e | Product name | 2 | 20250304 |
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63323-241-20 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-1af6-a2ce-e063-dadaa90aadf7 | Glycophos |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-241-20 | Glycophos | 20 mL in 1 VIAL, PLASTIC | INJECTION, SOLUTION | 20 | 3 | |
| 63323-241-20 | Glycophos | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-241-20 | ML - Milliliter | 63323-241 | 9e14bbc9-c26b-43b1-ba63-bdd82fd993c4 | 1 | 2013-06-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| SODIUM GLYCEROPHOSPHATE ANHYDROUS | ACTIVE INGREDIENT | YP1H63LJ2K | GLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| PHOSPHATE ION | ACTIVE MOIETY | NK08V8K8HR | GLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1423812 | Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection | PSN | dcd92dc7-c6f9-4866-9edd-c95d5097c4e5 | 3 |
| 1423807 | sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection | PSN | dcd92dc7-c6f9-4866-9edd-c95d5097c4e5 | 3 |
| 1423812 | 20 ML sodium glycerophosphate 216 MG/ML Injection [Glycophos] | SBD | dcd92dc7-c6f9-4866-9edd-c95d5097c4e5 | 3 |
| 1423807 | 20 ML sodium glycerophosphate 216 MG/ML Injection | SCD | dcd92dc7-c6f9-4866-9edd-c95d5097c4e5 | 3 |
| 1423812 | 20 ML Glycophos 216 MG/ML Injection | SY | dcd92dc7-c6f9-4866-9edd-c95d5097c4e5 | 3 |
| 1423812 | Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) per 20 ML Injection | SY | dcd92dc7-c6f9-4866-9edd-c95d5097c4e5 | 3 |
| 1423807 | sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) per 20 ML Injection | SY | dcd92dc7-c6f9-4866-9edd-c95d5097c4e5 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63323-241-20 | 63323024120 | 10 VIAL, PLASTIC in 1 CARTON (63323-241-20) > 20 mL in 1 VIAL, PLASTIC | 2013-05-13 | 0000-00-00 | No | No | Current |